Bob Salim

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · Journal of Clinical Oncology · 2019 · 386 citations · Full text

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · Journal for ImmunoTherapy of Cancer · 2021 · 137 citations · Full text

Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets

Nina Bhardwaj, Philip Friedlander, Anna C. Pavlick et al. · Nature Cancer · 2020 · 115 citations

Vaccination, Dendritic Cell Subsets, Anti-dec-205-ny-eso-1 Vaccine +10

Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry

Philip J. Mease, Scott Stryker, Mei Liu et al. · Arthritis Research & Therapy · 2021 · 23 citations · Full text

Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice

Gary L. Craig, Keith Knapp, Bob Salim et al. · Rheumatology and Therapy · 2021 · 22 citations · Full text